scholarly article | Q13442814 |
P2093 | author name string | Roger J Hajjar | |
Djamel Lebeche | |||
Judith K Gwathmey | |||
Elie Chemaly | |||
Marwan Refaat | |||
P2860 | cites work | Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. | Q33197914 |
Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments | Q35055736 | ||
A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling | Q36082162 | ||
Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 | ||
Conditional lineage ablation to model human diseases | Q36310580 | ||
Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure | Q36704776 | ||
Wnt-1 regulation of connexin43 in cardiac myocytes | Q37174801 | ||
Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocyte gap junctions | Q42443715 | ||
Influence of beta1-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and beta-adrenoceptor kinase in human atrium | Q43720872 | ||
L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices | Q44145600 | ||
Adrenergic-receptor polymorphisms and heart failure | Q44175864 | ||
Effects of Na(+)/Ca(2+)-exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. | Q44796804 | ||
Altered connexin43 expression produces arrhythmia substrate in heart failure | Q47324941 | ||
Alterations of gene expression in failing myocardium following left ventricular assist device support | Q47806965 | ||
Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy | Q48666103 | ||
Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support | Q49142828 | ||
Modulation of action potential duration on myocyte hypertrophic pathways | Q50734294 | ||
Ventricular arrhythmias during left ventricular assist device support | Q51024507 | ||
Effect of acute unloading via head-up tilt on QTc prolongation in patients with ischemic or non-ischemic cardiomyopathy | Q51280560 | ||
Effects of left ventricular assist device therapy on ventricular arrhythmias | Q51485749 | ||
Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure | Q51509603 | ||
Mixed messages: transcription patterns in failing and recovering human myocardium | Q51539355 | ||
Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart | Q51630929 | ||
Heterogeneous Expression of Gap Junction Channels in the Heart Leads to Conduction Defects and Ventricular Dysfunction | Q63425482 | ||
In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis | Q64379144 | ||
Conditional gene targeting of connexin43: exploring the consequences of gap junction remodeling in the heart | Q74299117 | ||
Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure | Q74499660 | ||
Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure | Q74696316 | ||
Differential Regulation of Mitogen-Activated Protein Kinases in the Failing Human Heart in Response to Mechanical Unloading | Q77129991 | ||
Regression of Cellular Hypertrophy After Left Ventricular Assist Device Support | Q77142298 | ||
Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy | Q77534957 | ||
P433 | issue | 10 | |
P304 | page(s) | 1246-1252 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Pacing and Clinical Electrophysiology | Q2740882 |
P1476 | title | Ventricular arrhythmias after left ventricular assist device implantation | |
P478 | volume | 31 |
Q37564159 | "Pseudo" Faraday cage: a solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator |
Q84624258 | Asymptomatic Sustained Ventricular Fibrillation in a Patient With Left Ventricular Assist Device |
Q43857931 | Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator. |
Q30453787 | Concomitant Left Ventricular Assist Device Placement and Cryoablation for Treatment of Ventricular Tachyarrhythmias Associated With Heart Failure |
Q46260680 | Continuous monitoring of cardiac rhythms in left ventricular assist device patients. |
Q30413403 | Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias |
Q57626635 | EHRA/HRS/APHRS expert consensus on ventricular arrhythmias |
Q57626770 | EHRA/HRS/APHRS expert consensus on ventricular arrhythmias |
Q26796261 | European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society |
Q38571627 | European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. |
Q90622969 | Heart failure as a substrate and trigger for ventricular tachycardia |
Q35218622 | Heart monitoring using left ventricle impedance and ventricular electrocardiography in left ventricular assist device patients |
Q92454801 | Hurdles to Cardioprotection in the Critically Ill |
Q90047120 | ICD shocks in LVAD patients are not associated with increased subsequent mortality risk |
Q39881101 | Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients |
Q28477588 | Inhibition of HERG potassium channels by celecoxib and its mechanism |
Q37561926 | Ion-channel mRNA-expression profiling: Insights into cardiac remodeling and arrhythmic substrates |
Q37021783 | Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. |
Q38527309 | Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices |
Q38095316 | Management of ventricular arrhythmias in patients with ventricular assist devices |
Q37860871 | Managing long-term complications of left ventricular assist device therapy |
Q26747170 | Mechanical circulatory assist devices: a primer for critical care and emergency physicians |
Q38070702 | Mechanical circulatory support for heart failure: past, present and a look at the future |
Q37209518 | Outflow monitoring of a pneumatic ventricular assist device using external pressure sensors |
Q37826020 | Pharmacotherapy for Mechanical Circulatory Support: A Comprehensive Review |
Q38636227 | Physiologic outcome of varying speed rotary blood pump support algorithms: a review study |
Q38062581 | Potassium Channels inDrosophila: Historical Breakthroughs, Significance, and Perspectives |
Q83479556 | Reverse Electrophysiologic Remodeling After Cardiac Mechanical Unloading for End-Stage Nonischemic Cardiomyopathy |
Q46446980 | Risk of Mortality for Ventricular Arrhythmia in Ambulatory LVAD Patients |
Q35738389 | Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. |
Q39105822 | The Burden of Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation |
Q39101811 | The relationship between R-wave magnitude and ventricular volume during continuous left ventricular assist device assistance: experimental study. |
Q27009542 | Use of implantable cardioverter defibrillators in patients with left ventricular assist devices |
Q37801437 | Ventricular Tachycardia in the Era of Ventricular Assist Devices |
Q27026786 | Ventricular arrhythmias in patients with implanted ventricular assist devices: a contemporary review |
Q27002612 | Ventricular assist devices: pharmacological aspects of a mechanical therapy |
Q48042038 | Windkessel model of hemodynamic state supported by a pulsatile ventricular assist device in premature ventricle contraction |
Search more.